Literature DB >> 9330614

Biochemical and physicochemical characterization of normal and variant forms of human MTH1 protein with antimutagenic activity.

H Yakushiji1, F Maraboeuf, M Takahashi, Z S Deng, S Kawabata, Y Nakabeppu, M Sekiguchi.   

Abstract

8-Oxo-7,8-dihydro-2'-deoxyguanosine 5'-triphosphate (8-oxo-dGTP) is produced during cellular metabolism, and its misincorporation into DNA causes mutation. Human cells possess an enzyme that hydrolyzes 8-oxo-dGTP to the corresponding nucleoside monophosphate, thereby preventing misincorporation of 8-oxo-7,8-dihydroguanine into DNA. Sequence analyses of the MTH1 gene, encoding the 8-oxo-7,8-dihydro-2'-deoxyguanosine 5'-triphosphatase (8-oxo-dGTPase) protein in human cell lines revealed that a G to A base substitution frequently occurs at codon 83, which causes a change of valine to methionine in the MTH1 protein [Wu, C. et al., Biochem. Biophys. Res. Commun. 214 (1995) 1239-1245]. Here we isolated cDNAs for the two types of MTH1 protein and expressed them in Escherichia coli mutT-. cells, devoid of their own 8-oxo-dGTPase activity. The two forms of proteins were purified to physical homogeneity, and amino acid analyses confirmed that the variant protein, Met83-MTH1, indeed carries the corresponding amino acid substitution. Met83-MTH1, but not normal type Val83-MTH1, was separated into two peaks in hydrophobic interacting chromatography. 8-Oxo-dGTPase activity of Met83-MTH1 is more thermolabile than that of Val83-MTH1. Circular dichroism (CD) and fluorescence spectroscopic analyses confirmed this conclusion. CD further indicated that Met83-MTH1 has a higher alpha-helix content.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9330614     DOI: 10.1016/s0921-8777(97)00025-6

Source DB:  PubMed          Journal:  Mutat Res        ISSN: 0027-5107            Impact factor:   2.433


  7 in total

1.  Functional significance of conserved residues in the phosphohydrolase module of Escherichia coli MutT protein.

Authors:  H Shimokawa; Y Fujii; M Furuichi; M Sekiguchi; Y Nakabeppu
Journal:  Nucleic Acids Res       Date:  2000-09-01       Impact factor: 16.971

2.  OGG1, MYH and MTH1 gene variants identified in gastric cancer patients exhibiting both 8-hydroxy-2'-deoxyguanosine accumulation and low inflammatory cell infiltration in their gastric mucosa.

Authors:  Masanori Goto; Kazuya Shinmura; Hidetaka Yamada; Toshihiro Tsuneyoshi; Haruhiko Sugimura
Journal:  J Genet       Date:  2008-08       Impact factor: 1.166

3.  Crystallization and preliminary X-ray analysis of human MTH1 with a homogeneous N-terminus.

Authors:  Yukari Koga; Miyuki Inazato; Teruya Nakamura; Chie Hashikawa; Mami Chirifu; Asuka Michi; Taku Yamashita; Sachiko Toma; Akihiko Kuniyasu; Shinji Ikemizu; Yusaku Nakabeppu; Yuriko Yamagata
Journal:  Acta Crystallogr Sect F Struct Biol Cryst Commun       Date:  2012-12-20

4.  Human MTH1 protein hydrolyzes the oxidized ribonucleotide, 2-hydroxy-ATP.

Authors:  K Fujikawa; H Kamiya; H Yakushiji; Y Nakabeppu; H Kasai
Journal:  Nucleic Acids Res       Date:  2001-01-15       Impact factor: 16.971

5.  The GT to GC single nucleotide polymorphism at the beginning of an alternative exon 2C of human MTH1 gene confers an amino terminal extension that functions as a mitochondrial targeting signal.

Authors:  Yasunari Sakai; Hisanobu Oda; Daisuke Yoshimura; Masato Furuichi; Dongchon Kang; Shigenori Iwai; Toshiro Hara; Yusaku Nakabeppu
Journal:  J Mol Med (Berl)       Date:  2006-04-11       Impact factor: 4.599

6.  A novel Nudix hydrolase for oxidized purine nucleoside triphosphates encoded by ORFYLR151c (PCD1 gene) in Saccharomyces cerevisiae.

Authors:  Tatsuo Nunoshiba; Rikiya Ishida; Michi Sasaki; Shigenori Iwai; Yusaku Nakabeppu; Kazuo Yamamoto
Journal:  Nucleic Acids Res       Date:  2004-10-08       Impact factor: 16.971

7.  Mammalian enzymes for preventing transcriptional errors caused by oxidative damage.

Authors:  Toru Ishibashi; Hiroshi Hayakawa; Riyoko Ito; Masayuki Miyazawa; Yuriko Yamagata; Mutsuo Sekiguchi
Journal:  Nucleic Acids Res       Date:  2005-07-07       Impact factor: 16.971

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.